Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine.
Department of Clinical Epidemiology, Hyogo College of Medicine.
Circ J. 2018 Oct 25;82(11):2811-2819. doi: 10.1253/circj.CJ-17-1386. Epub 2018 Sep 26.
There is a scarcity of reports on the clinical characteristics and management practice in contemporary all-comer patients with acute decompensated heart failure (ADHF).
The Kyoto Congestive Heart Failure (KCHF) registry is a prospective observational cohort study enrolling 4,056 consecutive patients who had hospital admission due to ADHF without any exclusion criteria between October 2014 and March 2016 in the 19 participating hospitals in Japan. Baseline characteristics, clinical presentations, management, and in-hospital outcomes were compared between heart failure (HF) with reduced left ventricular ejection fraction (LVEF; HFrEF, LVEF <40%), HF with mid-range LVEF (HFmrEF, LVEF 40-49%), and HF with preserved LVEF (HFpEF, LVEF ≥50%). Of the 4,041 patients with documented LVEF, 1,744 (43%) had HFpEF; 746 (19%), HFmrEF; and 1,551 (38%), HFrEF. The median age was 80 years (IQR, 72-86 years) in the entire population, and was higher with increasing LVEF (P<0.001). The in-hospital mortality rate was higher in the HFrEF than in the HFmrEF and HFpEF groups (9.2%, 4.8%, and 5.1%, respectively, P<0.001).
This registry elucidated the clinical features and clinically relevant in-hospital outcomes in contemporary consecutive patients with ADHF in real-world clinical practice in Japan. When classified by LVEF, significant differences in characteristics and in-hospital outcomes existed between patients with HFrEF, HFmrEF, and HFpEF.
目前关于急性失代偿性心力衰竭(ADHF)的所有患者的临床特征和管理实践的报告较少。
京都充血性心力衰竭(KCHF)注册研究是一项前瞻性观察性队列研究,纳入了 2014 年 10 月至 2016 年 3 月期间日本 19 家参与医院因 ADHF 住院且无任何排除标准的 4056 例连续患者。比较了射血分数降低的心力衰竭(HFrEF,LVEF<40%)、射血分数中间范围的心力衰竭(HFmrEF,LVEF 40-49%)和射血分数保留的心力衰竭(HFpEF,LVEF≥50%)患者之间的基线特征、临床表现、治疗和住院结局。在有记录 LVEF 的 4041 例患者中,1744 例(43%)为 HFpEF;746 例(19%)为 HFmrEF;1551 例(38%)为 HFrEF。整个队列的中位年龄为 80 岁(IQR,72-86 岁),随 LVEF 增加而升高(P<0.001)。HFrEF 组的院内死亡率高于 HFmrEF 组和 HFpEF 组(分别为 9.2%、4.8%和 5.1%,P<0.001)。
该注册研究阐明了日本真实世界临床实践中当代连续 ADHF 患者的临床特征和具有临床意义的院内结局。根据 LVEF 分类,HFrEF、HFmrEF 和 HFpEF 患者在特征和院内结局方面存在显著差异。